Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 9/2009

01.09.2009 | Original article

The new face of nucleolin in human melanoma

verfasst von: Dorota Hoja-Łukowicz, Małgorzata Przybyło, Ewa Pocheć, Anna Drabik, Jerzy Silberring, Marcelina Kremser, Dirk Schadendorf, Piotr Laidler, Anna Lityńska

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Nucleolin is multifunctional protein mainly present in nucleoli but also detected in cytoplasm and plasma membranes. Extranuclear nucleolin differs from the nuclear form by its glycosylation. Studies on expression of nucleolin in breast cancer suggest a possible association to the metastatic cascade. In the present study, Vicia villosa lectin (VVL) precipitation followed by subsequent polyacrylamide gel electrophoresis and mass spectrometry analysis demonstrates nucleolin as a VVL-positive glycoprotein expressed in melanoma. The presence of VVL-positive nucleolin in the melanoma cell membrane and cytoplasm was confirmed by confocal microscopy. Using bioinformatic peptide prediction programs, nucleolin was shown to contain multiple possible MHC class-I binding peptides in its sequence which makes nucleolin an interesting melanoma marker and target for immunodiagnostic and possibly therapeutic purposes.
Literatur
1.
Zurück zum Zitat Aldi S, Della Giovampaola C, Focarelli R, Armini A, Ziche M, Finetti F, Rosati F (2009) A fucose-containing O-glycoepitope on bovine and human nucleolin. Glycobiology 19:337–343PubMedCrossRef Aldi S, Della Giovampaola C, Focarelli R, Armini A, Ziche M, Finetti F, Rosati F (2009) A fucose-containing O-glycoepitope on bovine and human nucleolin. Glycobiology 19:337–343PubMedCrossRef
2.
Zurück zum Zitat Bubenik J (2005) MHC class I down-regulation, tumour escape from immune surveillance and design of therapeutic strategies. Folia Biol (Praha) 51:1–2 Bubenik J (2005) MHC class I down-regulation, tumour escape from immune surveillance and design of therapeutic strategies. Folia Biol (Praha) 51:1–2
3.
Zurück zum Zitat Carpentier M, Morelle W, Coddeville B, Pons A, Masson M, Mazurie J, Legrand D (2005) Nucleolin undergoes partial N- and O-glycosylations in the extracellular cell compartment. Biochemistry 44:5804–5815PubMedCrossRef Carpentier M, Morelle W, Coddeville B, Pons A, Masson M, Mazurie J, Legrand D (2005) Nucleolin undergoes partial N- and O-glycosylations in the extracellular cell compartment. Biochemistry 44:5804–5815PubMedCrossRef
4.
Zurück zum Zitat Chen C, Chiang S, Yeh N (1991) Increased stability of nucleolin in proliferating cells by inhibition of its self-cleaving activity. J Biol Chem 266:7754–7758PubMed Chen C, Chiang S, Yeh N (1991) Increased stability of nucleolin in proliferating cells by inhibition of its self-cleaving activity. J Biol Chem 266:7754–7758PubMed
5.
Zurück zum Zitat Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 163:871–878PubMedCrossRef Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 163:871–878PubMedCrossRef
6.
Zurück zum Zitat Dall’Olio F (1996) Protein glycosylation in cancer biology: an overview. Clin Mol Pathol 49:126–135CrossRef Dall’Olio F (1996) Protein glycosylation in cancer biology: an overview. Clin Mol Pathol 49:126–135CrossRef
7.
Zurück zum Zitat Deng J-S, Ballou B, Hofmeister JK (1996) Internalization of anti-nucleolin antibody into viable HEp-2 cells. Mol Biol Rep 23:191–195PubMedCrossRef Deng J-S, Ballou B, Hofmeister JK (1996) Internalization of anti-nucleolin antibody into viable HEp-2 cells. Mol Biol Rep 23:191–195PubMedCrossRef
8.
Zurück zum Zitat Fonsatti E, Di Giacomo AM, Maio M (2004) Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy? J Trans Med 2:21CrossRef Fonsatti E, Di Giacomo AM, Maio M (2004) Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy? J Trans Med 2:21CrossRef
9.
Zurück zum Zitat Ginisty H, Sicard H, Roger B, Bouvet P (1999) Structure and function of nucleolin. J Cell Sci 112:761–772PubMed Ginisty H, Sicard H, Roger B, Bouvet P (1999) Structure and function of nucleolin. J Cell Sci 112:761–772PubMed
10.
Zurück zum Zitat Glithero A, Tormo J, Haurum JS, Arsequell G, Valencia G, Edwards J, Springer S, Townsend A, Pao YL, Wormald M, Dwek RA, Jones EY, Elliott T (1999) Crystal structures of two H-2Db/glycopeptides complexes suggest a molecular basis for CTL cross-reactivity. Immunity 10:63–74PubMedCrossRef Glithero A, Tormo J, Haurum JS, Arsequell G, Valencia G, Edwards J, Springer S, Townsend A, Pao YL, Wormald M, Dwek RA, Jones EY, Elliott T (1999) Crystal structures of two H-2Db/glycopeptides complexes suggest a molecular basis for CTL cross-reactivity. Immunity 10:63–74PubMedCrossRef
11.
Zurück zum Zitat Hakomori S (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99:10231–10233PubMedCrossRef Hakomori S (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99:10231–10233PubMedCrossRef
12.
Zurück zum Zitat Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R (2001) Identification of nucleolin as a new L-selectin ligand. Biochem J 360:531–538PubMedCrossRef Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R (2001) Identification of nucleolin as a new L-selectin ligand. Biochem J 360:531–538PubMedCrossRef
13.
Zurück zum Zitat Haurum JS, Arsequell G, Lellouch AC, Wong SY, Dwek RA, McMichael AJ, Elliott T (1994) Recognition of carbohydrate by major histocompatibility comlex class I-restricted, glycopeptides-specific cytotoxic T lymphocytes. J Exp Med 180:739–744PubMedCrossRef Haurum JS, Arsequell G, Lellouch AC, Wong SY, Dwek RA, McMichael AJ, Elliott T (1994) Recognition of carbohydrate by major histocompatibility comlex class I-restricted, glycopeptides-specific cytotoxic T lymphocytes. J Exp Med 180:739–744PubMedCrossRef
14.
Zurück zum Zitat Haurum JS, Tan L, Arsequell G, Frodsham P, Lellouch AC, Moss PA, Dwek RA, McMichael AJ, Elliott T (1995) Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition. Eur J Immunol 25:3270–3276PubMedCrossRef Haurum JS, Tan L, Arsequell G, Frodsham P, Lellouch AC, Moss PA, Dwek RA, McMichael AJ, Elliott T (1995) Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition. Eur J Immunol 25:3270–3276PubMedCrossRef
15.
Zurück zum Zitat Haurum JS, Hoier IB, Arsequell G, Neisig A, Valencia G, Zeuthen J, Neefjes J, Elliott T (1999) Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med 190:145–150PubMedCrossRef Haurum JS, Hoier IB, Arsequell G, Neisig A, Valencia G, Zeuthen J, Neefjes J, Elliott T (1999) Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med 190:145–150PubMedCrossRef
16.
Zurück zum Zitat Hoja-Łukowicz D, Lityńska A, Pocheć E, Przybyło M, Kremser E, Ciołczyk-Wierzbicka D, Laidler P (2006) Identification of PNA-positive proteins in the primary uveal melanoma cell line by mass spectrometry. Acta Biol Cracov Ser Zool 48:39–47 Hoja-Łukowicz D, Lityńska A, Pocheć E, Przybyło M, Kremser E, Ciołczyk-Wierzbicka D, Laidler P (2006) Identification of PNA-positive proteins in the primary uveal melanoma cell line by mass spectrometry. Acta Biol Cracov Ser Zool 48:39–47
17.
Zurück zum Zitat Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS, Krust B (2000) The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 261:312–328PubMedCrossRef Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS, Krust B (2000) The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 261:312–328PubMedCrossRef
18.
Zurück zum Zitat Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y (2006) The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107:3564–3571PubMedCrossRef Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y (2006) The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107:3564–3571PubMedCrossRef
19.
Zurück zum Zitat Joo EJ, ten Dam GB, van Kuppevelt TH, Toida T, Linhardt RJ, Kim YS (2005) Nucleolin: acharan sulfate-binding protein on the surface of cancer cells. Glycobiology 15:1–9PubMedCrossRef Joo EJ, ten Dam GB, van Kuppevelt TH, Toida T, Linhardt RJ, Kim YS (2005) Nucleolin: acharan sulfate-binding protein on the surface of cancer cells. Glycobiology 15:1–9PubMedCrossRef
20.
Zurück zum Zitat Kanitakis J, Al-Rifai I, Faure M, Claudy A (1998) Differential expression of cancer associated antigen T (Thomsen-Friedenrich) and Tn to the skin in primary and metastatic carcinomas. J Clin Pathol 51:588–592PubMedCrossRef Kanitakis J, Al-Rifai I, Faure M, Claudy A (1998) Differential expression of cancer associated antigen T (Thomsen-Friedenrich) and Tn to the skin in primary and metastatic carcinomas. J Clin Pathol 51:588–592PubMedCrossRef
21.
Zurück zum Zitat Kastrup IB, Stevanovic S, Arsequell G, Valencia G, Zeuthen J, Rammensee HG, Elliot T, Haurum JS (2000) Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo. Tissue Antigens 56:129–135PubMedCrossRef Kastrup IB, Stevanovic S, Arsequell G, Valencia G, Zeuthen J, Rammensee HG, Elliot T, Haurum JS (2000) Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo. Tissue Antigens 56:129–135PubMedCrossRef
22.
Zurück zum Zitat Laidler P, Lityńska A, Hoja-Łukowicz D, Łabędź M, Przybyło M, Ciołczyk-Wierzbicka D, Pocheć E, Trębacz E, Kremser E (2006) Characterization of glycosylation and adherent properties of melanoma cell lines. Cancer Immunol Immunother 55:112–118PubMedCrossRef Laidler P, Lityńska A, Hoja-Łukowicz D, Łabędź M, Przybyło M, Ciołczyk-Wierzbicka D, Pocheć E, Trębacz E, Kremser E (2006) Characterization of glycosylation and adherent properties of melanoma cell lines. Cancer Immunol Immunother 55:112–118PubMedCrossRef
23.
Zurück zum Zitat Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedCrossRef Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedCrossRef
24.
25.
Zurück zum Zitat Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomiany MC, Carpentier M, Briand JP, Mazurier J, Hovanessian AG (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271:303–317PubMedCrossRef Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomiany MC, Carpentier M, Briand JP, Mazurier J, Hovanessian AG (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271:303–317PubMedCrossRef
26.
Zurück zum Zitat Lisowska E (2002) The role of glycosylation in protein antigenic properties. CMLS, Cell Mol Life Sci 59:445–455CrossRef Lisowska E (2002) The role of glycosylation in protein antigenic properties. CMLS, Cell Mol Life Sci 59:445–455CrossRef
27.
Zurück zum Zitat Monzavi-Karbassi B, Luo P, Jousheghany F, Torres-Quinones M, Cunto-Amesty G, Artaud C, Kieber-Emmos T (2004) A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res 64:2162–2166PubMedCrossRef Monzavi-Karbassi B, Luo P, Jousheghany F, Torres-Quinones M, Cunto-Amesty G, Artaud C, Kieber-Emmos T (2004) A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res 64:2162–2166PubMedCrossRef
28.
Zurück zum Zitat Renkvist N, Castelli C, Robbins PF, Parmanini G (2001) A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 50:3–15PubMedCrossRef Renkvist N, Castelli C, Robbins PF, Parmanini G (2001) A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 50:3–15PubMedCrossRef
29.
Zurück zum Zitat Said EA, Courty J, Svab J, Delbe J, Krust B, Hovanessian AG (2005) Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FASEB J 272:4646–4659 Said EA, Courty J, Svab J, Delbe J, Krust B, Hovanessian AG (2005) Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FASEB J 272:4646–4659
30.
Zurück zum Zitat Salazar R, Brandt R, Kellermann J, Krantz S (2000) Purification and characterization of a 200 kDa fructosyllysine-specific binding protein from cell membranes of U937 cells. Glycoconjugate J 17:713–716CrossRef Salazar R, Brandt R, Kellermann J, Krantz S (2000) Purification and characterization of a 200 kDa fructosyllysine-specific binding protein from cell membranes of U937 cells. Glycoconjugate J 17:713–716CrossRef
31.
Zurück zum Zitat Singhal A, Fohn M, Hakomori S (1991) Induction of α-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular response for active immunotherapy in mice. Cancer Res 51:1406–1411PubMed Singhal A, Fohn M, Hakomori S (1991) Induction of α-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular response for active immunotherapy in mice. Cancer Res 51:1406–1411PubMed
32.
Zurück zum Zitat Speir JA, Abde-Motal UM, Jondal M, Wilson IA (1999) Crystal structure of an MHC class I presented glycopeptides that generates carbohydrate-specific CTL. Immunity 10:51–61PubMedCrossRef Speir JA, Abde-Motal UM, Jondal M, Wilson IA (1999) Crystal structure of an MHC class I presented glycopeptides that generates carbohydrate-specific CTL. Immunity 10:51–61PubMedCrossRef
33.
Zurück zum Zitat Springer GF (1989) Tn epitope (N-acetyl-D-galactosamineα-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol Immunol 26:1–5PubMedCrossRef Springer GF (1989) Tn epitope (N-acetyl-D-galactosamineα-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol Immunol 26:1–5PubMedCrossRef
34.
Zurück zum Zitat Srivastava M, Pollard HB (1999) Molecular dissection of nucleolin’s role in growth and cell proliferation: new insights. FASEB J 13:1911–1922PubMed Srivastava M, Pollard HB (1999) Molecular dissection of nucleolin’s role in growth and cell proliferation: new insights. FASEB J 13:1911–1922PubMed
35.
Zurück zum Zitat Thies A, Moll I, Berger J, Schumacher U (2001) Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation. Br J Cancer 84:819–823PubMedCrossRef Thies A, Moll I, Berger J, Schumacher U (2001) Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation. Br J Cancer 84:819–823PubMedCrossRef
36.
Zurück zum Zitat Weiner LM, Dhodapkar MV, Ferrone S (2009) Monoclonal antibodies for cancer immunotherapy. Lancet 373:1033–1040PubMedCrossRef Weiner LM, Dhodapkar MV, Ferrone S (2009) Monoclonal antibodies for cancer immunotherapy. Lancet 373:1033–1040PubMedCrossRef
Metadaten
Titel
The new face of nucleolin in human melanoma
verfasst von
Dorota Hoja-Łukowicz
Małgorzata Przybyło
Ewa Pocheć
Anna Drabik
Jerzy Silberring
Marcelina Kremser
Dirk Schadendorf
Piotr Laidler
Anna Lityńska
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 9/2009
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-009-0705-8

Weitere Artikel der Ausgabe 9/2009

Cancer Immunology, Immunotherapy 9/2009 Zur Ausgabe

Acknowledgement to Reviewers

Acknowledgement

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.